It has been found that higher expression of RELMβ is observed in H. pylori-positive intestinal metaplasia, dysplasia, intestinal-type and diffuse-type gastric cancers, whereas elimination of H. pylori significantly attenuate RELMβ expression in intestinal metaplasia [113]. Here, RETNLB is linked to dysplasia.